Literature DB >> 24725670

ARDS associated with pneumonia caused by avian influenza A H7N9 virus treated with extracorporeal membrane oxygenation.

Xiao Tang1, Hangyong He1, Bing Sun1, Jun Wan1, Chengjun Ban1, Chunyan Zhang1, Shuqin Wang1, Jingen Xia1, Jie Li1, Yingmei Liu2, Bin Cao2, Zhaohui Tong1.   

Abstract

This is a sporadic H7N9 avian influenza case that was the first severe imported case in Beijing and the first case of Hebei province in China. A 61-year-old female who had rapidly progressive pneumonia with respiratory distress and bilateral exduation and consolidation changes on chest X-ray and computerized tomography (CT) scan that did not respond to ordinary antibiotics was diagnosed with influenza A (H7N9) infection in our hospital on July 19, 2013. Intravenous peramivir, veno-venous extracorporeal membrane oxygenation (VV-ECMO) and continuous veno-venous hemofiltration were given on the same day of lab diagnosis because of severe acute respiratory distress syndrome and acute renal failure. With antimicrobial therapy and other supportive treatment, clinical symptoms and oxygenation of the patient improved gradually. VV-ECMO was successfully removed on the 13th day. The testing for influenza A (H7N9) turned negative on day 16 since the antivirus therapy. Twenty-three days after hospitalization, blood stream infection with multidrug-resistant Acinetobacter Baumannii occurred, which lead to septic shock and death. Whether or not the influenza season in north China, the influenza screening should be carried out as a conventional test for the patients who are suspected of viral pneumonia. For the patients who need mechanical ventilation and ECMO support, the lung protective strategy under the guidance of transpulmonary pressure may be helpful for recovering the lung.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  H7N9 avian influenza pneumonia; extracorporeal membrane oxygenation; multi-drug resistant Acinetobacter Baumannii; nosocomial infections

Mesh:

Year:  2014        PMID: 24725670     DOI: 10.1111/crj.12140

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  8 in total

Review 1.  Pandemic potential of avian influenza A (H7N9) viruses.

Authors:  Tokiko Watanabe; Shinji Watanabe; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Trends Microbiol       Date:  2014-09-25       Impact factor: 17.079

2.  Neuraminidase of Influenza A Virus Binds Lysosome-Associated Membrane Proteins Directly and Induces Lysosome Rupture.

Authors:  Xiangwu Ju; Yiwu Yan; Qiang Liu; Ning Li; Miaomiao Sheng; Lifang Zhang; Xiao Li; Zhu Liang; Fengming Huang; Kangtai Liu; Yan Zhao; Yanxu Zhang; Zhen Zou; Jianchao Du; Ying Zhong; Huandi Zhou; Peng Yang; Huijun Lu; Mingyao Tian; Dangsheng Li; Jianming Zhang; Ningyi Jin; Chengyu Jiang
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

3.  Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration.

Authors:  Linna Huang; Wei Zhang; Yi Yang; Wenjuan Wu; Weihua Lu; Han Xue; Hongsheng Zhao; Yunfu Wu; Jia Shang; Lihua Cai; Long Liu; Donglin Liu; Yeming Wang; Bin Cao; Qingyuan Zhan; Chen Wang
Journal:  BMC Infect Dis       Date:  2018-01-08       Impact factor: 3.090

4.  RIP3 deficiency ameliorates inflammatory response in mice infected with influenza H7N9 virus infection.

Authors:  Yu-Lin Xu; Hai-Lin Tang; Hao-Ran Peng; Ping Zhao; Zhong-Tian Qi; Wen Wang
Journal:  Oncotarget       Date:  2017-04-25

5.  Close Relationship between cIAP2 and Human ARDS Induced by Severe H7N9 Infection.

Authors:  Chu Qin; Xiao-Yan Sai; Xiu-Fen Qian; Yan Wu; Li-Fei Zou; Hong-Mei Wang; Tao Bian; Zheng Yan
Journal:  Biomed Res Int       Date:  2019-04-07       Impact factor: 3.411

Review 6.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

7.  Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.

Authors:  Amber Farooqui; Linxi Huang; Suwu Wu; Yingmu Cai; Min Su; Pengzhou Lin; Weihong Chen; Xibin Fang; Li Zhang; Yisu Liu; Tiansheng Zeng; Stephane G Paquette; Adnan Khan; Alyson A Kelvin; David J Kelvin
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

Review 8.  Peramivir injection in the treatment of acute influenza: a review of the literature.

Authors:  Ashley Wester; Avinash K Shetty
Journal:  Infect Drug Resist       Date:  2016-08-22       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.